Adjuvant radiotherapy after surgery for prostate cancer

JAMA

Volumn 300, Issue 18, 2008, Pages 2119-

  Parker, Chris ^a   Sydes, Matthew ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b MRC CLINICAL TRIALS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; HORMONAL THERAPY; HUMAN; LETTER; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SALVAGE THERAPY; MALE; NOTE; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL;

HUMANS; MALE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SALVAGE THERAPY;

EID: 56149127924     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2008.562     Document Type: Letter

References (2)

1. Trock BJ, Han M, Freedland SJ, et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA. 2008;299(23):2760-2769.
2. Parker C, Clarke N, Logue J, et al; The RADICALS Trial Management Group. RADICALS (Radiotherapy and Androgen Deprivation in Combination after Local Surgery). Clin Oncol (R Coll Radiol). 2007;19(3):167-171.